Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData’s new report, “Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global interventional cardiology devices market. The report provides market landscape, competitive landscape and market trends information on the interventional cardiology devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the market’s competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Key segments covered include Coronary Stents, PTCA Balloons, Cardiac Catheters, Coronary Guidewires, Arteriotomy Closure Devices, Intravascular Ultrasound Systems and PTCA Coronary Drug Eluting Balloons (DEB).
• Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
• Qualitative analysis of key market trends, market drivers, and restraints by each category within the interventional cardiology devices market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Boston Scientific Corporation, Abbott Laboratories, Medtronic, Cordis Corporation and Terumo Corporation.

Reasons to buy

• Develop business strategies by understanding the trends and developments that are driving the interventional cardiology devices market globally.
• Design and develop your product development, marketing and sales strategies.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
• What’s the next big thing in the interventional cardiology devices market landscape? - Identify, understand and capitalize.Make more informed business decisions from the insightful and in-depth analysis of the global interventional cardiology devices market and the factors shaping it.

Contents

1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 GlobalData Report Guidance

3 DISEASE OVERVIEW - CORONARY HEART DISEASE (CHD)

3.1 Introduction
3.2 Etiology
3.3 Pathophysiology
3.4 Symptoms
3.5 Risk Factors
3.6 Epidemiology
  3.6.1 Prevalence of Coronary Heart Disease (CHD) in the US
  3.6.2 Prevalence of Coronary Heart Disease (CHD) in Europe

4 INTERVENTIONAL CARDIOLOGY DEVICES - OVERVIEW

4.1 Arteriotomy Closure Devices
4.2 Cardiac Catheters
  4.2.1 Angiography Catheters
  4.2.2 Guiding Catheters
4.3 PTCA Coronary Drug Eluting Balloons (DEB)
4.4 Coronary Guidewires
4.5 Coronary Stents
  4.5.1 Bare Metal Stents (BMS)
  4.5.2 Drug Eluting Stents (DES)
4.6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
  4.6.1 FW Balloons
  4.6.2 Over the Wire Balloons
  4.6.3 Rapid Exchange Balloons
  4.6.4 PTCA Cutting and Scoring Balloons
4.7 Intravascular Ultrasound Systems (IVUS)
  4.7.1 Intravascular Ultrasound Catheter
  4.7.2 Intravascular Ultrasound System Console

5 INTERVENTIONAL CARDIOLOGY DEVICES: MARKET CHARACTERIZATION

5.1 Interventional Cardiology Devices Market, Global, Revenue ($bn), Historic, 2003–2010
5.2 Interventional Cardiology Devices Market, Global, Revenue ($bn), Forecast, 2010–2017
5.3 Interventional Cardiology Devices Market, Key Trends
  5.3.1 Transradial Intervention Promises Robust Growth of Percutaneous Coronary Intervention Procedures in the Future
  5.3.2 The Market is Witnessing an Increasing Shift towards Percutaneous Coronary Intervention (PCI) Procedures Compared to Coronary Artery Bypass Graft Procedures
  5.3.3 Decrease in Mortality Rate Associated with Coronary Heart Disease (CHD) due to Adoption of PCI Procedures has Increased Physicians’ Confidence
  5.3.4 Reducing Price Trend in the Coronary Stents Market to Continue due to Intense Competition between New Entrants and Existing Companies
5.4 Interventional Cardiology Devices, Market Dynamics
  5.4.1 Market Drivers
  5.4.2 Market Restraints

6 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: SEGMENT ANALYSIS

6.1 Coronary Stents Market, Global, Revenue ($bn), Historic, 2003–2010
6.2 Coronary Stents Market, Global, Revenue ($m), Forecast, 2010-–2017
6.3 PTCA Balloons Market, Global, Revenue ($m), Historic, 2003–2010
6.4 PTCA Balloons Market, Global, Revenue ($m), Forecast, 2010—2017
6.5 Cardiac Catheters Market, Global, Revenue ($m), Historic, 2003–2010
6.6 Cardiac Catheters Market, Global, Revenue ($m), Forecast, 2010-–2017
6.7 Coronary Guidewires Market, Global, Revenue ($m), Historic, 2003–2010
6.8 Coronary Guidewires Market, Global, Revenue ($m), Forecast, 2010-–2017
6.9 Arteriotomy Closure Devices Market, Global, Revenue ($m), Historic, 2003–2010
6.10 Arteriotomy Closure Devices Market, Global, Revenue ($m), Forecast, 2010-–2017
6.11 Intravascular Ultrasound Systems Market, Global, Revenue ($m), Historic, 2003–2010
6.12 Intravascular Ultrasound Systems Market, Global, Revenue ($m), Forecasts, 2010-–2017
6.13 PTCA Coronary Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), Historic, 2003–2010
6.14 PTCA Coronary Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), Forecasts, 2010-–2017

7 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, REVENUE ($M), BY COUNTRY, REVENUE ($M), 2003–2017

7.1 Interventional Cardiology Devices Market, US, Revenue ($m), Historic, 2003–2010
7.2 Interventional Cardiology Devices Market, US, Revenue ($m), Forecast, 2010–2017
7.3 Interventional Cardiology Devices Market, Canada, Revenue ($m), Historic, 2003–2010
7.4 Interventional Cardiology Devices Market, Canada, Revenue ($m), Forecast, 2010–2017
7.5 Interventional Cardiology Devices Market, UK, Revenue ($m), Historic, 2003–2010
7.6 Interventional Cardiology Devices Market, UK, Revenue ($m), Forecast, 2010–2017
7.7 Interventional Cardiology Devices Market, France, Revenue ($m), Historic, 2003–2010
7.8 Interventional Cardiology Devices Market, France, Revenue ($m), Forecast, 2010–2017
7.9 Interventional Cardiology Devices Market, Germany, Revenue ($m), Historic, 2003–2010
7.10 Interventional Cardiology Devices Market, Germany, Revenue ($m), Forecast, 2010–2017
7.11 Interventional Cardiology Devices Market, Italy, Revenue ($m), Historic, 2003–2010
7.12 Interventional Cardiology Devices Market, Italy, Revenue ($m), Forecast, 2010–2017
7.13 Interventional Cardiology Devices Market, Spain, Revenue ($m), Historic, 2003–2010
7.14 Interventional Cardiology Devices Market, Spain, Revenue ($m), Forecast, 2010–2017
7.15 Interventional Cardiology Devices Market, Japan, Revenue ($m), Historic, 2003–2010
7.16 Interventional Cardiology Devices Market, Japan, Revenue ($m), Forecast, 2010–2017
7.17 Interventional Cardiology Devices Market, China, Revenue ($m), Historic, 2003–2010
7.18 Interventional Cardiology Devices Market, China, Revenue ($m), Forecast, 2010–2017
7.19 Interventional Cardiology Devices Market, Australia, Revenue ($m), Historic, 2003–2010
7.20 Interventional Cardiology Devices Market, Australia, Revenue ($m), Forecast, 2010–2017
7.21 Interventional Cardiology Devices Market, India, Revenue ($m), Historic, 2003–2010
7.22 Interventional Cardiology Devices Market, India, Revenue ($m), Forecast, 2010–2017
7.23 Interventional Cardiology Devices Market, Brazil, Revenue ($m), Historic, 2003–2010
7.24 Interventional Cardiology Devices Market, Brazil, Revenue ($m), Forecast, 2010–2017

8 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: STRATEGIC COMPETITIVE ASSESSMENT

8.1 Interventional Cardiology Devices Market, Global, Company Share (%), 2010
8.2 Interventional Cardiology Devices, Market Opportunities and Risk Evaluation
8.3 Boston Scientific Corporation
  8.3.1 Key Marketed Products
  8.3.2 Boston Scientific Corporation, Internal Factors Analysis
8.4 Abbott Laboratories
  8.4.1 Key Marketed Products
  8.4.2 Abbott Laboratories, Internal Factors Analysis
8.5 Medtronic, Inc.
  8.5.1 Key Marketed Products
  8.5.2 Medtronic, Internal Factors Analysis
8.6 Cordis Corporation
  8.6.2 Key Marketed Products
  8.6.3 Cordis Corporation, Internal Factors Analysis
8.7 Terumo Corporation
  8.7.2 Key Marketed Products
  8.7.3 Terumo Corporation, Internal Factors Analysis

9 GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES: STRATEGIC PIPELINE ASSESSMENT

9.1 Interventional Cardiology Devices: Pipeline Products Summary
9.2 Bioabsorbable Stents, List of Pipeline Products
  9.2.1 Bioabsorbable Stents, Pipeline Assessment, by Development Stage
  9.2.2 Bioabsorbable Stents, Pipeline Assessment, by Unmet Need
  9.2.3 Bioabsorbable Stents Market, Key Pipeline Products
Drug Eluting Absorbable Metal Scaffold
9.3 PTCA Coronary Drug Eluting Balloons (DEB)
  9.3.1 PTCA Coronary Drug Eluting Balloons Market, Key Pipeline Products
9.4 Drug Eluting Stents, List of Pipeline Products
  9.4.1 Drug Eluting Stents Market, Key Pipeline Products
9.5 Bare Metal Stents, List of Pipeline Products
9.6 Bifurcation Stents, List of Pipeline Products
  9.6.1 Bifurcation Stents Market, Key Pipeline Products
9.7 PTCA Balloons
  9.7.1 PTCA Balloons Market, Key Pipeline Products
9.8 Cardiac Catheters
  9.8.1 Cardiac Catheters Market, Key Pipeline Products
9.9 Coronary Guidewires
  9.9.1 Coronary Guidewires Market, Key Pipeline Products
9.10 Intravascular Ultrasound Systems (IVUS)
9.11 Arteriotomy Closure Devices
  9.11.1 Arteriotomy Closure Devices Market, Key Pipeline Products
9.12 Other Interventional Cardiology Devices

10 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: M&A LANDSCAPE

10.1 Key Acquisitions
  10.1.1 Biosensors International Acquires CardioMind
  10.1.2 Opto Circuits Completes Acquisition of N.S. Remedies
  10.1.3 Medtronic Completes Acquisition of Invatec and Affiliated Companies
  10.1.4 Boston Scientific Acquires Labcoat
  10.1.5 St. Jude Medical Acquires Stake in Micell Technologies
  10.1.6 Lake Region Medical Acquires Brivant Medical
  10.1.7 Biosensors International Group Acquires Remaining 50% Interest in JW Medical Systems
  10.1.8 Royal DSM Acquires The Polymer Technology Group

11 APPENDIX

11.1 Definitions
  11.1.1 Interventional Cardiology
  11.1.2 Arteriotomy Closure Devices
  11.1.3 Cardiac Catheters
  11.1.4 Coronary Guidewires
  11.1.5 Coronary Stents
  11.1.6 PTCA Balloons
  11.1.7 PTCA Coronary Drug Eluting Balloons (DEB)
11.2 Acronyms
11.3 Sources
11.4 Research Methodology
  11.4.1 Secondary Research
  11.4.2 Primary Research
  11.4.3 Models
  11.4.4 Forecasts
  11.4.5 Expert Panel
11.5 GlobalData Consulting
11.6 Contact Us
11.7 Disclaimer 143

LIST OF TABLES

Table 1: Interventional Cardiology Devices Market, Global, Revenue ($bn), 2003–2010
Table 2: Interventional Cardiology Devices Market, Global, Revenue ($bn), 2010–2017
Table 3: Percutaneous Coronary Intervention (PCI) Procedures vs. Coronary Artery Bypass Graft (CABG) Procedures (millions), Global, 2007-2010
Table 4: Age-Adjusted Coronary Heart Disease (CHD) Mortality Rate (per 100,000), The US, 2000–2007
Table 5: Coronary Stents Market, Average Selling Price ($), The US, 2003–2010
Table 6: Drug Eluting Stents Market, List of Key Clinical Trials
Table 7: Cardiac Catheterization Procedures (millions), The US, 2006–2010
Table 8: Intravascular Ultrasound Systems Market, Average Selling Price ($), Developed Countries, 2010
Table 9: Coronary Stents Market, Global, Revenue ($bn), 2003–2010
Table 10: Coronary Stents Market, Global, Revenue ($bn), 2010–2017
Table 11: PTCA Balloons Market, Global, Revenue ($m), 2003–2010
Table 12: PTCA Balloons Market, Global, Revenue ($m), 2010–2017
Table 13: Cardiac Catheters Market, Global, Revenue ($m), 2003–2010
Table 14: Cardiac Catheters Market, Global, Revenue ($m), 2010–2017
Table 15: Coronary Guidewires Market, Global, Revenue ($m), 2003–2010
Table 16: Coronary Guidewires Market, Global, Revenue ($m), 2010–2017
Table 17: Arteriotomy Closure Devices Market, Global, Revenue ($m), 2003–2010
Table 18: Arteriotomy Closure Devices Market, Global, Revenue ($m), 2010–2017
Table 19: Intravascular Ultrasound Systems Market, Global, Revenue ($m), 2003–2010
Table 20: Intravascular Ultrasound Systems Market, Global, Revenue ($m), 2010–2017
Table 21: PTCA Coronary Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), 2003–2010
Table 22: PTCA Coronary Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), 2010–2017
Table 23: Interventional Cardiology Devices Market, US, Revenue ($m), 2003–2010
Table 24: Interventional Cardiology Devices Market, US, Revenue ($m), 2010–2017
Table 25: Interventional Cardiology Devices Market, Canada, Revenue ($m), 2003–2010
Table 26: Interventional Cardiology Devices Market, Canada, Revenue ($m), 2010–2017
Table 27: Interventional Cardiology Devices Market, UK, Revenue ($m), 2003–2010
Table 28: Interventional Cardiology Devices Market, UK, Revenue ($m), 2010–2017
Table 29: Interventional Cardiology Devices Market, France, Revenue ($m), 2003–2010
Table 30: Interventional Cardiology Devices Market, France, Revenue ($m), 2010–2017
Table 31: Interventional Cardiology Devices Market, Germany, Revenue ($m), 2003–2010
Table 32: Interventional Cardiology Devices Market, Germany, Revenue ($m), 2010–2017
Table 33: Interventional Cardiology Devices Market, Italy, Revenue ($m), 2003–2010
Table 34: Interventional Cardiology Devices Market, Italy, Revenue ($m), 2010–2017
Table 35: Interventional Cardiology Devices Market, Spain, Revenue ($m), 2003–2010
Table 36: Interventional Cardiology Devices Market, Spain, Revenue ($m), 2010–2017
Table 37: Interventional Cardiology Devices Market, Japan, Revenue ($m), 2003–2010
Table 38: Interventional Cardiology Devices Market, Japan, Revenue ($m), 2010–2017
Table 39: Interventional Cardiology Devices Market, China, Revenue ($m), 2003–2010
Table 40: Interventional Cardiology Devices Market, China, Revenue ($m), 2010–2017
Table 41: Interventional Cardiology Devices Market, Australia, Revenue ($m), 2003–2010
Table 42: Interventional Cardiology Devices Market, Australia, Revenue ($m), 2010–2017
Table 43: Interventional Cardiology Devices Market, India, Revenue ($m), 2003–2010
Table 44: Interventional Cardiology Devices Market, India, Revenue ($m), 2010–2017
Table 45: Interventional Cardiology Devices Market, Brazil, Revenue ($m), 2003–2010
Table 46: Interventional Cardiology Devices Market, Brazil, Revenue ($m), 2010–2017
Table 47: Interventional Cardiology Devices Market, Global, Company Share (%), Revenue ($m), 2010
Table 48: Boston Scientific Corporation, Marketed Products, Product Type, Features and Benefits, 2011
Table 49: Abbott Laboratories, Key Marketed Products, Product Type, Features and Benefits, 2011
Table 50: Medtronic, Inc., Key Marketed Products, Product Type, Features and Benefits, 2011
Table 51: Cordis Corporation, Key Marketed Products, Product Type, Features and Benefits, 2011
Table 52: Terumo Corporation, Key Marketed Products, Product Type, Features and Benefits, 2011
Table 53: Interventional Cardiology Devices, Pipeline Products Summary, 2011
Table 54: Bioabsorbable Stents Market, List of Pipeline Products, Global, 2011
Table 55: Absorb, Product Status
Table 56: Drug Eluting Absorbable Metal Scaffold, Product Status
Table 57: Myolimus Eluting Coronary Stents-Bioabsorbable Polymer - Product Status
Table 58: PTCA Coronary Drug Eluting Balloons (DEB) Market, List of Pipeline Products, Global, 2011
Table 59: SeQuent Please, Product Status
Table 60: Next Generation Rapamycin (Sirolimus)-Based DEB, Product Status
Table 61: DIOR Paclitaxel-Eluting Coronary Balloon Catheter, Product Status
Table 62: Drug Eluting Stents, List of Pipeline Products, Global, 2011
Table 63: BioFreedom, Product Status
Table 64: BioMatrix Drug Eluting Stent, Product Status
Table 65: CYPHER Sirolimus-eluting Coronary Stents – AMI, Product Status
Table 66: DESyne BD Novolimus Eluting Coronary Stents System – Product Status
Table 67: Endeavor Resolute – Product Status
Table 68: Genius TAXCOR I – Product Status
Table 69: Infinnium Paclitaxel Eluting Coronary Stents System – Product Status
Table 70: MAHOROBA Stent – Product Status
Table 71: Bare Metal Stents Market, List of Pipeline Products, Global, 2011
Table 72: Bifurcation Stents Market, List of Pipeline Products, Global, 2011
Table 73: AXXESS Biolimus A9 Eluting Bifurcation Stent System, Product Status
Table 74: PTCA Balloons Market, List of Pipeline Products, Global, 2011
Table 75: Zylon Zero-Fold Angioplasty Balloon Catheter – Product Status
Table 76: Avion Bifurcation RX2 - Product Status
Table 77: Cardiac Catheters Market, List of Pipeline Products, Global, 2011
Table 78: Stingray CTO Re-Entry System – Product Status
Table 79: MyoCath – Product Status
Table 80: Genie Catheter – Product Status
Table 81: Diamondback 360°-Calcified Coronary Lesions – Product Status
Table 82: Coronary Guidewires Market, List of Pipeline Products, Global, 2011
Table 83: Wrist Artery Guidewire – Product Status
Table 84: Intravascular Ultrasound Systems (IVUS) Market, List of Pipeline Products, Global, 2011
Table 85: Arteriotomy Closure Devices Market, List of Pipeline Products, Global, 2011
Table 86: EpiClose Plus – Product Status
Table 87: ExoSeal Vascular Closure Device – Product Status
Table 88: Second Generation CloSys Hemostasis Device – Product Status
Table 89: FastSeal Bioabsorbable Vascular Access Closure System – Product Status
Table 90: Other Interventional Cardiology Devices Market, List of Pipeline Products, Global, 2010
Table 91: Biosensors International Acquires CardioMind, 2010
Table 92: Opto Circuits Completes Acquisition of N.S. Remedies, 2010
Table 93: Medtronic Completes Acquisition of Invatec and Affiliated Companies, 2010
Table 94: Boston Scientific Acquires Labcoat, 2009
Table 95: St. Jude Medical Acquires Stake In Micell Technologies, 2008
Table 96: Lake Region Medical Acquires Brivant Medical, 2008
Table 97: Biosensors International Group Acquires Remaining 50% Interest In JW Medical Systems, 2008
Table 98: Royal DSM Acquires The Polymer Technology Group, 2008 135

LIST OF FIGURES

Figure 1: Interventional Cardiology Devices, Market Segmentation
Figure 2: Interventional Cardiology Devices Market, Global, Revenue ($bn), 2003–2010
Figure 3: Interventional Cardiology Devices Market, Global, Revenue ($bn), 2010–2017
Figure 4: Interventional Cardiology Devices Market, Transradial Intervention Vs. Femoral Access Intervention
Figure 5: Percutaneous Coronary Intervention (PCI) Procedures vs. Coronary Artery Bypass Graft (CABG) Procedures, Global, 2007-2010
Figure 6: Age-Adjusted Coronary Heart Disease (CHD) Mortality Rate (per 100,000), The US, 2000–2007
Figure 7: Coronary Stents Market, Average Selling Price ($), The US, 2003–2010
Figure 8: Interventional Cardiology Devices, Market Dynamics
Figure 9: Bioabsorbable Stents Vs Drug Eluting Stents (DES), Technology Benchmarking
Figure 10: PTCA Coronary Drug Eluting Balloons (DEB) Vs Drug Eluting Stents (DES), Technology Benchmarking
Figure 11: Cardiac Catheterization Procedures (millions), The US, 2006–2010
Figure 12: Coronary Stents Market, Global, Revenue ($bn), 2003–2010
Figure 13: Coronary Stents Market, Global, Revenue ($bn), 2010–2017
Figure 14: PTCA Balloons Market, Global, Revenue ($m), 2003–2010
Figure 15: PTCA Balloons Market, Global, Revenue ($m), 2010–2017
Figure 16: Cardiac Catheters Market, Global, Revenue ($m), 2003–2010
Figure 17: Cardiac Catheters Market, Global, Revenue ($m), 2010–2017
Figure 18: Coronary Guidewires Market, Global, Revenue ($m), 2003–2010
Figure 19: Coronary Guidewires Market, Global, Revenue ($m), 2010–2017
Figure 20: Arteriotomy Closure Devices Market, Global, Revenue ($m), 2003–2010
Figure 21: Arteriotomy Closure Devices Market, Global, Revenue ($m), 2010–2017
Figure 22: Intravascular Ultrasound Systems Market, Global, Revenue ($m), 2003–2010
Figure 23: Intravascular Ultrasound Systems Market, Global, Revenue ($m), 2010–2017
Figure 24: PTCA Coronary Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), 2003–2010
Figure 25: PTCA Coronary Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), 2010-2017
Figure 26: Interventional Cardiology Devices Market, US, Revenue ($m), 2003–2010
Figure 27: Interventional Cardiology Devices Market, US, Revenue ($m), 2010–2017
Figure 28: Interventional Cardiology Devices Market, Canada, Revenue ($m), 2003–2010
Figure 29: Interventional Cardiology Devices Market, Canada, Revenue ($m), 2010–2017
Figure 30: Interventional Cardiology Devices Market, UK, Revenue ($m), 2003–2010
Figure 31: Interventional Cardiology Devices Market, UK, Revenue ($m), 2010–2017
Figure 32: Interventional Cardiology Devices Market, France, Revenue ($m), 2003–2010
Figure 33: Interventional Cardiology Devices Market, France, Revenue ($m), 2010–2017
Figure 34: Interventional Cardiology Devices Market, Germany, Revenue ($m), 2003–2010
Figure 35: Interventional Cardiology Devices Market, Germany, Revenue ($m), 2010–2017
Figure 36: Interventional Cardiology Devices Market, Italy, Revenue ($m), 2003–2010
Figure 37: Interventional Cardiology Devices Market, Italy, Revenue ($m), 2010–2017
Figure 38: Interventional Cardiology Devices Market, Spain, Revenue ($m), 2003–2010
Figure 39: Interventional Cardiology Devices Market, Spain, Revenue ($m), 2010–2017
Figure 40: Interventional Cardiology Devices Market, Japan, Revenue ($m), 2003–2010
Figure 41: Interventional Cardiology Devices Market, Japan, Revenue ($m), 2010–2017
Figure 42: Interventional Cardiology Devices Market, China, Revenue ($m), 2003–2010
Figure 43: Interventional Cardiology Devices Market, China, Revenue ($m), 2010–2017
Figure 44: Interventional Cardiology Devices Market, Australia, Revenue ($m), 2003–2010
Figure 45: Interventional Cardiology Devices Market, Australia, Revenue ($m), 2010–2017
Figure 46: Interventional Cardiology Devices Market, India, Revenue ($m), 2003–2010
Figure 47: Interventional Cardiology Devices Market, India, Revenue ($m), 2010–2017
Figure 48: Interventional Cardiology Devices Market, Brazil, Revenue ($m), 2003–2010
Figure 49: Interventional Cardiology Devices Market, Brazil, Revenue ($m), 2010–2017
Figure 50: Interventional Cardiology Devices Market, Global, Company Share (%) , 2010
Figure 51: Interventional Cardiology Devices, Market Opportunities and Risk Evaluation
Figure 52: Boston Scientific Corporation, Internal Factors Analysis
Figure 53: Abbott Laboratories, Internal Factors Analysis
Figure 54: Medtronic, Inc., Internal Factors Analysis
Figure 55: Cordis Corporation, Internal Factors Analysis
Figure 56: Terumo Corporation, Internal Factors Analysis
Figure 57: Interventional Cardiology Devices, Pipeline Products Summary, 2011
Figure 58: Bioabsorbable Stents Market, Pipeline Assessment, by Development Stage
Figure 59: Bioabsorbable Stents Market, Pipeline Assessment, by Unmet Need
Figure 60: Comparison of In Vivo Acute Stent Recoil Between The Bioabsorbable Everolimus-Eluting Coronary Stents And The Everolimus-eluting Cobalt Chromium Coronary Stents: Insights From The ABSORB And SPIRIT Trials
Figure 61: Myolimus Eluting Coronary Stents-Bioabsorbable Polymer – First-In-Man Study Of The Myolimus Eluting Coronary Stents System
Figure 62: Paclitaxel-eluting Balloon Versus Paclitaxel-eluting Stent In Small Coronary Vessel Disease
Figure 63: CYPHER Sirolimus-eluting Coronary Stents – AMI – Use Of The Cypher Sirolimus-Eluting Coronary Stents In Acute Myocardial Infarction Treated With Balloon Angioplasty
Figure 64: DESyne BD Novolimus Eluting Coronary Stents System – Novolimus Eluting Coronary Stents System with Bioabsorbable Polymer: Nine-Month Clinical and Six-Month Angiographic Results
Figure 65: Endeavor Resolute - The Clinical Response Evaluation Of The Medtronic Endeavor CR ABT-578 Eluting Coronary Stents System In De Novo Native Coronary Artery Lesions
Figure 66: Genius TAXCOR I – Evaluating The Efficiency Of Genius TAXCOR In A Multi-Center Clinical Trial Study
Figure 67: Infinnium Paclitaxel Eluting Coronary Stents System – Safety And Efficacy Of The Infinnium Paclitaxel Eluting Stent In Single De Novo Native Coronary Artery Lesions
Figure 68: Infinnium Paclitaxel Eluting Coronary Stents System – Safety And Efficacy Of Infinnium Stent In The Patients With CAD In More Then One Vessel
Figure 69: MAHOROBA Stent – First-In-Man Study Using The Tacrolimus-Eluting Bioabsorbable Polymer-Coated Cobalt–Chromium MAHOROBA Stent 117

COMPANIES MENTIONED

Boston Scientific Corporation
Abbott Laboratories
Medtronic, Inc.
Cordis Corporation
Terumo Corporation Skip to top